Company
United StatesPublic company, NASDAQ: JAZZJazz Pharmaceuticals, Inc (NASDAQ: JAZZ), Palo Alto, CA – FDA Inspections
Inspection records and compliance data for Jazz Pharmaceuticals, Inc in Palo Alto, California. 7 FDA inspections on record (1 OAI), 2 Form 483s, last inspected June 10, 2019. Publicly traded as NASDAQ: JAZZ.
Company Profile
This profile covers Jazz Pharmaceuticals, Inc based in Palo Alto, California, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 1
- VAI
- 4
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected May 6, 2011. Last inspected June 10, 2019.
Most cited issue areas
- Failure to develop written procedures3 inspections
- Late submission of 15-day report3 inspections
- Failure to investigate serious, unexpected events2 inspections
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 10, 2019 | VAI | Human Drugs · Postmarket Surv. and Epidemiology | 1094205 |
| March 10, 2017 | Not classified | Human Drugs | 1004087 |
| July 20, 2016 | NAI | Human Drugs · Drug Quality Assurance | 978492 |
| January 27, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 979392 |
| April 4, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 876999 |
| May 30, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 780816 |
| May 6, 2011 | OAI | Human Drugs · Bioresearch Monitoring | 721416 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Jazz Pharmaceuticals, Inc
Stock ticker
JAZZ
Exchange
NASDAQ
Share price
$240.37
Market cap
$15.4B
Price as of
November 13, 2026
FEI Number
3005615655
Address
3170 Porter Dr, Palo Alto, California 94304, United States
Country
United States
ID: 51d45380-8ab8-428b-8239-f7bf9368ebaa